Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729) ROIC %: 0.20% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920729 Guangdong Winsun Bio Pharmaceutical Co Ltd BJSE:920729
74 GF Score
Price ¥7.00
GF Value ¥5.67
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Guangdong Winsun Bio Pharmaceutical Co ROIC %?

Guangdong Winsun Bio Pharmaceutical Co BJSE:920729 74 ROIC % is 0.20% as of Jun. 2026. GuruFocus rates BJSE:920729 with a GF Score™ of 74/100 and a GF Value™ of ¥5.67 (Modestly Overvalued). The stock has 7 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Guangdong Winsun Bio Pharmaceutical Co's annualized return on invested capital (ROIC %) for the quarter that ended in Jun. 2026 was 0.20%.

As of today (2026-08-30), Guangdong Winsun Bio Pharmaceutical Co's WACC % is 11.79%. Guangdong Winsun Bio Pharmaceutical Co's ROIC % is 3.21% (calculated using TTM income statement data). Guangdong Winsun Bio Pharmaceutical Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Guangdong Winsun Bio Pharmaceutical Co  (BJSE:920729) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Guangdong Winsun Bio Pharmaceutical Co's WACC % is 11.79%. Guangdong Winsun Bio Pharmaceutical Co's ROIC % is 3.21% (calculated using TTM income statement data). Guangdong Winsun Bio Pharmaceutical Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Guangdong Winsun Bio Pharmaceutical Co ROIC % Related Terms


Guangdong Winsun Bio Pharmaceutical Co ROIC % Historical Data

* Premium members only.

The historical data trend for Guangdong Winsun Bio Pharmaceutical Co's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Winsun Bio Pharmaceutical Co ROIC % Chart

Guangdong Winsun Bio Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.63 18.20 10.75 5.75 4.86

Guangdong Winsun Bio Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.01 4.32 4.83 3.38 0.20

BJSE:920729 vs VRTX, REGN, RVMD: ROIC % Comparison

For the Biotechnology subindustry, Guangdong Winsun Bio Pharmaceutical Co's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Winsun Bio Pharmaceutical Co ROIC % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guangdong Winsun Bio Pharmaceutical Co's ROIC % distribution charts can be found below:

* The bar in red indicates where Guangdong Winsun Bio Pharmaceutical Co's ROIC % falls into.


BJSE:920729
74GF Score
Guangdong Winsun Bio Pharmaceutical Co Ltd BJSE:920729
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangdong Winsun Bio Pharmaceutical Co ROIC % Calculation

Guangdong Winsun Bio Pharmaceutical Co's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROIC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=34.603 * ( 1 - 10.69% )/( (639.893 + 632.089)/ 2 )
=30.9039393/635.991
=4.86 %

where

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=793.856 - 92.418 - ( 69.349 - max(0, 111.316 - 293.155+69.349))
=632.089

Guangdong Winsun Bio Pharmaceutical Co's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Jun. 2026 is calculated as:

ROIC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=1.26 * ( 1 - 0% )/( (610.149 + 622.219)/ 2 )
=1.26/616.184
=0.20 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of 0.20% mean?
Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729) has a ROIC % of 0.20% as of Jun. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Guangdong Winsun Bio Pharmaceutical Co and its competitors.
Is Guangdong Winsun Bio Pharmaceutical Co's ROIC % too high?
Guangdong Winsun Bio Pharmaceutical Co's current ROIC % is 0.20%. Overall, Guangdong Winsun Bio Pharmaceutical Co has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guangdong Winsun Bio Pharmaceutical Co's ROIC % compare to VRTX and REGN?
Guangdong Winsun Bio Pharmaceutical Co's ROIC % of 0.20% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Biotechnology company?
A good ROIC % depends on the Biotechnology industry context. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Guangdong Winsun Bio Pharmaceutical Co and its competitors. Guangdong Winsun Bio Pharmaceutical Co's current ROIC % is 0.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Winsun Bio Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥5.67, compared to a current price of ¥7.00 — trading 23.5% above its estimated fair value. The current ROIC % is 0.20%. Guangdong Winsun Bio Pharmaceutical Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729), the current ROIC % is 0.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729) Overvalued in 2026?

Based on GuruFocus' analysis, Guangdong Winsun Bio Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥7.00 is trading 23.5% above its estimated GF Value™ of ¥5.67. GuruFocus considers Guangdong Winsun Bio Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for BJSE:920729:

  • ROIC %: 0.20%
  • GF Value™: ¥5.67 vs. price of ¥7.00 (23.5% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920729 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangdong Winsun Bio Pharmaceutical Co Business Description

Address No. 35 Tianyuan West Road, Huangpu District, Guangdong Province, Guangzhou City, CHN, 511356
Guangdong Winsun Bio Pharmaceutical Co Ltd is involved in the field of veterinary biological products. It is an enterprise integrating research and development, production, sales, and service of veterinary biological products. It engages in the production of embryotoxin live vaccines, cytotoxic live vaccines, bacterial live vaccines, avian influenza inactivated vaccines, cytotoxic inactivated vaccines, embryotoxin inactivated vaccines, bacterial inactivated vaccines, swine fever live vaccines (rabbit source); veterinary use of Biological products.
74GF Score

Get the complete analysis for BJSE:920729

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.00
Price
¥5.67
GF Value